🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome

Recruitingn/aAges 18 Years - 65 YearsAllSultan Abdulhamid Han Training and Research Hospi…
NCT07114913 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to compare central sensitization parameters between carpal tunnel syndrome (CTS) patients with extra median symptom distribution and those with typical, median nerve-related symptoms. Extra median sensory spread, observed in some CTS patients beyond the anatomical boundaries of the median nerve, may reflect central sensitization mechanisms. Using the Central Sensitization Inventory and pressure pain threshold measurements, this study will assess whether extra median symptom patterns are associated with increased central sensitization.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Having been diagnosed with carpal tunnel syndrome based on clinical and electrodiagnostic findings * Being between 18 and 65 years of age * Being literate * Agreeing to participate in the study Exclusion Criteria: * Having a history of concomitant diabetes, systemic inflammatory disease, active infection, or malignancy * Being \<18 and \>65 years of age * Being illiterate * Refusing to participate in the study * Having a disease associated with neuropathic pain, such as polyneuropathy, radiculopathy, or multiple sclerosis * History of injection or surgery for CTS within the last 6 months
💊

What it tests

  • Nerve ultrasound
  • Nerve conduction studies
  • Pressure pain threshold
📍

Where

1 site
Sultan Abdülhamid Han Training and Research Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy